The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
      View

Press Release / May 20, 1996
Contrast Media and Custom Services are two key areas in Hovione's strategic analysis document

      View

Article / Mar 01, 1994
Managing with the aim of sustainable developmentUNEP Industry and Environment, March 1994

      View

Article / Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and ManufacturabilityPharma's Almanac, Q4 2016, October 23, 2016

        View Article }}

Article / Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and ManufacturabilityPharma's Almanac, Q4 2016, 23 October 2016

      View

Article / Nov 18, 2016
A True DiversifierMacau Business, November 18, 2016

      View

Article / Nov 07, 2016
The fine chemicals sector remembers Peter PollakC&EN, November 7, 2016

      View

Article / Oct 01, 2016
Rx-360: An Industry Group Like No OtherPharma's Almanac, October 2016

      View

News / Dec 22, 2016
Season's GreetingsSeason's Greetings from Hovione

        View Patent }}

Patent / Dec 28, 2016
Continuous production of particles, micro- and/or nanoparticles, particulate amorphous solid dispersions, particulate co-crystals and pharmaceutical compns.WO 2016156841

        View Patent }}

Patent / Dec 28, 2016
Electrophilic reagents for monohalomethylation, their preparation and their usesUS 9290446

Browser not supported

Search

Types

Press Room

Categories

Contrast Media and Custom Services are two key areas in Hovione's strategic analysis document

Managing with the aim of sustainable development

Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability

Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability

A True Diversifier

The fine chemicals sector remembers Peter Pollak

Rx-360: An Industry Group Like No Other

Season's Greetings

Continuous production of particles, micro- and/or nanoparticles, particulate amorphous solid dispersions, particulate co-crystals and pharmaceutical compns.

Electrophilic reagents for monohalomethylation, their preparation and their uses